Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO

 

Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
07:22

SGO 2022 Conference Coverage on VuMedi

SGO 2022 on Shared Decision Making in Frontline Maintenance Therapy for Ovarian Cancer: A Qualitative Assessment

FEATURING Ashley Haggerty
  • 203 views
  • March 24, 2022
  • 1
10:41

SGO 2022 Conference Coverage on VuMedi

SGO 2022: Development of an Interactive Precision Medicine Dashboard to Aid in Completion of Germline and HRD Tumor Testing for ND Ovarian Cancer to Improve the Use of PARPi Frontline Maintenance

FEATURING Ashley Haggerty
  • 48 views
  • March 24, 2022
10:16

Brian Slomovitz

Treating Metastatic/Recurrent Cervical Cancer With Tisotumab Vedotin

  • 597 views
  • April 4, 2022
  • 2
11:28

SGO 2022 Conference Coverage on VuMedi

SGO 2022 on Clinical Outcomes of Ovarian Cancer Patients Treated With the Novel Engineered Cytokine Nemvaleukin Alfa + Pembro: Recent Data From ARTISTRY-1

FEATURING Ira Winer
  • 241 views
  • April 1, 2022
  • 1
13:30

SGO 2022 Conference Coverage on VuMedi

SGO 2022 on a Randomized Phase 3 Trial of IP vs. IV Carboplatin With Dose-Dense Weekly Paclitaxel in Ovarian/Fallopian Tube/Primary Peritoneal Carcinoma

FEATURING Keiichi Fujiwara
  • 263 views
  • April 1, 2022
  • 1
23:34

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022

Updates in Gynecologic Oncology: Better Strategy in 2022

FEATURING Gottfried Konecny
  • 705 views
  • April 1, 2022
  • 3
07:31

SGO 2022 Conference Coverage on VuMedi

SGO 2022 on Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: A Cost-Effectiveness Analysis

FEATURING David Barrington
  • 232 views
  • April 7, 2022
  • 1
08:27

UCLA Health

Recurrent Cervical Cancer: Updates on Management

FEATURING Ritu Salani
  • 488 views
  • April 20, 2022
  • 4
05:21

SGO 2022 Conference Coverage on VuMedi

SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or Platinum-Sensitive Recurrent Uterine Serous Carcinoma

FEATURING Marina Frimer
  • 194 views
  • April 7, 2022
08:08

SGO 2022 Conference Coverage on VuMedi

SGO 2022 Final OS Results From SOLO3: Phase III Trial Assessing Olaparib Monotherapy vs. Non-Platinum Chemo in Heavily Pretreated Patients With Germline BRCA1 and/or BRCA2m Platinum-Sensitive Relapsed Ovarian Cancer

FEATURING Richard Penson
  • 327 views
  • April 7, 2022
  • 1
11:09

Krishnansu Tewari

Treating Metastatic or Recurrent Cervical Cancer With an Antibody-Drug Conjugate

  • 315 views
  • May 2, 2022
  • 3
07:50

Nebraska Oncology Society

Nebraska Oncology Society Advances in Cervical Cancer

FEATURING Lan Coffman
  • 43 views
  • October 3, 2022
09:01

Yale Cancer Center

Radiotherapy Applications for Gynecological Cancers

FEATURING Daniela Addeo
  • 144 views
  • August 4, 2022
  • 3
26:19

Total Health

Cervical Cancer: Key Data Review

FEATURING Chrisann Kyi
  • 223 views
  • October 11, 2022
  • 3
10:47

Jyoti Mayadev

Advances in Immunotherapy for Cervical Cancer: Recent Developments and Future Directions

  • 179 views
  • October 25, 2022
  • 1
06:44

Cedars Sinai

Goals of Care and QoL in Patients With Metastatic Cervical Cancer: What Oncologists Should Discuss With Patients

FEATURING Bobbie J. Rimel
  • 118 views
  • November 30, 2022